Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova)Д. В. Буханова, С. И. Глухова, Г. М. Тарасова et al.|Meditsinskiy sovet = Medical Council|2019Cited by 14
IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF A TWO-YEAR FOLLOW-UP STUDYM. S. Naumtseva, Yu. V. Muravyev, Б. С. Белов et al.|Rheumatology Science and Practice|2017Cited by 9
Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseasesД. В. Буханова, М. Е. Диатроптов, Б. С. Белов et al.|Meditsinskiy sovet = Medical Council|2018Cited by 9
INVESTIGATION OF IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUSГ. М. Тарасова, Т. В. Попкова, Б. С. Белов et al.|Rheumatology Science and Practice|2018Cited by 7
Immunogenicity and efficiency of a 23-valent pneumococcal vaccine in patients with rheumatoid arthritis: results of a 5-year follow up studyД. В. Буханова, N. V. Demidova, M. S. Sergeeva et al.|Modern Rheumatology Journal|2018Cited by 6